These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33094954)

  • 1. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.
    Magris R; De Re V; Maiero S; Fornasarig M; Guarnieri G; Caggiari L; Mazzon C; Zanette G; Steffan A; Canzonieri V; Cannizzaro R
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00238. PubMed ID: 33094954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
    Miftahussurur M; Waskito LA; Aftab H; Vilaichone RK; Subsomwong P; Nusi IA; Syam AF; Ratanachu-Ek T; Doohan D; Siregar G; Rezkitha YAA; Fauzia KA; Mahachai V; Yamaoka Y
    PLoS One; 2020; 15(4):e0230064. PubMed ID: 32271765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection.
    Veijola LI; Oksanen AM; Sipponen PI; Rautelin HI
    World J Gastroenterol; 2010 Jan; 16(1):83-8. PubMed ID: 20039453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
    Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
    Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
    Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
    Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
    Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
    Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
    Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia.
    Leja M; Cine E; Rudzite D; Vilkoite I; Huttunen T; Daugule I; Rumba-Rozenfelde I; Pimanov S; Liepniece-Karele I; Pahomova J; Purmalis K; Eglitis J; Pirags V; Dzerve V; Erglis A
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
    Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
    Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
    Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
    Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.